This combination product of Metformin HCl and Sitagliptin phosphate acts as an AMPK activator and DPP-4 inhibitor, suppressing hepatic gluconeogenesis to modulate glucose levels. It is widely used in diabetes research for both in vitro mechanistic studies and in vivo metabolic models.
Molekulargewicht:
670.93
CAS Nummer:
[1011232-08-8]
Formel:
C20H30ClF6N10O5P
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten